<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1447">
 <bold>Conclusions:</bold> The SAATELLITE study represents an innovative pre-emptive therapy approach to prevent S aureus nosocomial pneumonia in MV patients, by utilizing the novel monoclonal antibody MEDI4893, thereby offering a new paradigm in S aureus infection management in high-risk patients.
</p>
